Timäus, Charles http://orcid.org/0000-0002-7154-2427
Vogelgsang, Jonathan
Kis, Bernhard
Radenbach, Katrin
Wolff-Menzler, Claus
Mavridou, Kiriaki
Gyßer, Stephan
Hessmann, Philipp
Wiltfang, Jens
Funding for this research was provided by:
Projekt DEAL
Article History
Received: 12 August 2019
Accepted: 13 January 2020
First Online: 29 January 2020
Change Date: 5 June 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00406-021-01275-7
Compliance with ethical standards
:
: Stephan Gyßer is a full-time employee of GSG consultant. Jens Wiltfang is supported by an Ilídio Pinho professorship and iBiMED (UID/BIM/04501/2013) and FCT project PTDC/DTP_PIC/5587/2014 at the University of Aveiro, Portugal. Jens Wiltfang received honoraria for consulting activities, lectures or advisory board participation from Pfizer, Eli Lilly, Hoffmann-La-Roche, MSD Sharp + Dome, Janssen-Cilag GmbH, Immungenetics AG, Boehringer Ingelheim and Novartis. Jens Wiltfang holds patents EP1270592B1, US 6,849,416 B2, EP2095128B1 and EP3105589A1. Bernhard Kis received honoraria for authorships, publisher activities, advisory board participation and speaker fees from ecomed, Hogrefe, Medicine, Dt. Krankenhausgesellschaft and Shire. Claus Wolff-Menzler received honoraria for consulting activities from GSG, Vitro GmbH, LVR, Janssen, LWL, Mibeg-Institute, Agfa/Orbis, DKI, PKM, Asklepios, Alexianer, ID-Schwarz, LivaNova, Servier, ZEB and DKCT.
: This article does not contain any studies with human participants performed by any of the authors.